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INTRODUCTION
Excess intra-hepatic fat (IHF), commonly termed steatosis, is present in approximately one third of patients with colorectal liver metastases (CLM). [1] [2] [3] Moderate to severe steatosis (triglyceride content >33% 4 ) and steatohepatitis (steatosis with hepatocyte ballooning, lobular inflammation and fibrosis 4 ) are associated with increased post-operative morbidity (two-fold increase) and peri-operative mortality (2.8-to 10-fold increase). 5, 6 Retrospective studies have shown excess body mass index (BMI), diabetes and pre-operative chemotherapy are associated with steatosis and/or steatohepatitis in the resection specimen. 3, 5, 7 Within the general population, visceral adipose tissue (VAT) but not subcutaneous adipose tissue (SAT), correlates with intra-heaptic fat (IHF). [8] [9] [10] Consistent with this, serum surrogate biomarkers of insulin resistance independently predict for IHF. [9] [10] [11] However, IHF is determined indirectly by non-invasive imaging modalities, either using ultrasound scans in large cohorts, 12 or in clinical practice, by pre-operative chemical-shift MR (CS-MR). 13 Magnetic resonance (MR) spectroscopy may offer greater performance characteristics but its utility is limited to the research setting. 14, 15 To directly inform the above relationships, and pre-operative assessment, we used the opportunity in patients undergoing liver resection, to quantify IHF by digital histological assessment (D-IHF) and related this with CT-derived anthropometrics (VAT and SAT), insulin-related serum biomarkers, and IHF estimated by CS-MR.
METHODS
Patients
The study schema is outlined in (Figure 1 ). Patients planned for resection of colorectal liver metastases (CLM) at North Manchester General Hospital, Manchester, United Kingdom, were prospectively recruited between January 2012 and June 2013; all gave informed consent. All patients underwent pre-operative CT, CT-PET and CS-MR imaging as routine clinical care; the decision to proceed to resection was made at a multidisciplinary team M A N U S C R I P T
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4 meeting. 16 Individuals who were recruited but did not undergo resection were still included if an intra-operative biopsy that included background liver was performed. We excluded patients undergoing re-do resections (where the regenerated liver is likely to be unrepresentative) and patients treated with more than one line of pre-operative chemotherapy (where there may be increased risk of chemotherapy-induced liver injury and/or cancer-related weight loss). Pre-operative chemotherapy was defined as any chemotherapy administered within the six-month period preceding liver resection (the definition used in a recent National Clinical Research Network Trial). 17 Data on complications, pre-operative liver enzymes levels and length of hospital were collected.
Height, weight (to derive BMI), waist circumference (WC) and hip circumference (to derive waist-to-hip ratio [WHR]) were measured before surgery. Waist circumference was measured at the level of the anterior superior iliac spines; hip circumference at the gluteal level.
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Development of digital histology quantification of intra-hepatic fat (D-IHF)
Seven digital images of routine H&E slides of the background liver were taken by a single consultant hepatobiliary pathologist (MaRa) at x10 magnification and maximum resolution.
Each photograph was imported into Adobe Photoshop and converted to a greyscale image; the levels were then adjusted to increase the contrast. The image was magnified and the magic wand tool used to capture areas of fat deposition, leaving behind normal parenchyma.
The D-IHF percentage was determined by counting the number of highlighted pixels divided by the total number using the histogram tool. Individual percentages were recorded and a mean value was derived for each patient from the 7 digital images. Seven slides were chosen based on a previous digital morphometry study reporting minimal intra-and interobserver variability for 7 slides. 18 The validity of this new 7-slide technique was tested by examining 43 images in one patient. The mean digitally quantified histological score from the 43 images was 4.30. We randomly sampled this data with replacement as samples n = 40, n = 35, n = 30….. n = 4 M A N U S C R I P T 4 were also performed.
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CT-derived VAT and SAT volumes
Pre-operative CT scans were analyzed using OsiriX software to determine SAT and VAT areas and volumes. To measure SAT area, a mean +/-2 standard deviation fat attenuation value was derived by drawing regions of interest (ROIs) in the subcutaneous fat compartment at the level of the right renal hilum. A narrow fat attenuation window specific to each patient avoided areas of connective tissue, fibrosis and vessels. The edge of the peritoneal cavity was traced to leave behind only subcutaneous fat and the Grow Region 2D tool used to input upper and lower thresholds for fat attenuation. The same technique was used for VAT area, drawing an ROI in the visceral fat and subtracting the SAT. Any fat deep to the rectus sheath and outer edge of para-spinal muscles, including inter-muscular fat between quadratus lumborum and erector spinae was included in the visceral fat compartment.
To account for changes in SAT and VAT compartments at different vertebral levels 19 we derived SAT and VAT volumes. A 120mm section running cranially from the L5-S1 disc was used with the Grow Region 3D tool to derive volumes from individual areas. Each CT parameter was measured twice to assess intra-rater variability; measurements were repeated by an independent observer (AAP) to explore inter-rater variability (see supplemental material). There was good to excellent agreement for all measurements
(range of CCCs: 0.86-0.99). In general, inter-rater variability was greater than intra-rater variability.
Serum biomarkers of insulin resistance
Pre-surgery fasting (at least 4 hours) plasma levels of glucose and serum insulin, adiponectin, leptin and fetuin-A were determined following blood collection in standard serum tubes and centrifuged at 3,000rpm for 15min at 5°C. Serum (3-5mls) was stored at - 
Relative hepatic fat content on chemical shift MR imaging
Relative IHF content was determined from pre-operative CS-MR scans, and cross-checked against D-IHF. We measured In-and Out-signal intensity in three 1.5-2cm 2 Regions of Interest (ROI) in liver segments II, V and VIII using a PACS (Picture Archiving and Communication System) workstation. ROI intensity was derived using the standard formula (
. 23 Each ROI was placed distant from major vessels, ducts and tumour
following consensus between the same two observers (EP and PM). Where it was not possible to use segments II, V and VIII, the nearest suitable segment was chosen.
Statistical analyses
All analyses were performed using Stata, version 12. Predictors of intra-hepatic fat content were explored using multivariable linear regression models. To reduce the right skewness of the distributions of some insulin-related biomarkers, the base 2 logarithmic transformation was used, which leads to a convenient interpretation: the beta coefficient associated with a change of one unit on the log2 scale corresponds to the slope associated with a doubling in biomarker level on the original scale.
Because of the large number of variables and the anticipated high levels of correlations, we used a factor-cluster method as shown in Figure S3 
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
8
RESULTS
Baseline characteristics
Thirty-seven patients were recruited but following exploratory laparotomy: 4 patients did not proceed to resection, of which open biopsies were taken in two. Thus, there were 35 patients eligible for D-IHF quantification.(median age 64 years, 20 males, 15 treated with pre-operative chemotherapy, see Table 1 ).
Gender-specific differences were observed across anthropometric measurements, 
Correlation analysis
Results for the correlation analysis are displayed in Table 2 . In general, pre-operative 
Comparison with published literature
Gender-specific differences for anthropometrics and serum biomarkers of insulin resistance (for example, increased VAT in men), have been reported previously within the metabolic literature, 8, 9, 25 as have the relationships we observed between individual anthropometrics, CT-measurements and serum biomarkers (for example, leptin correlating with subcutaneous but not visceral fat). 11, 26 The principle finding in this study -that IHF is significantly associated with measures of insulin resistance rather than physical measures of body and visceral fat -has also been described previously, but only where IHF content was quantified indirectly using MR spectroscopy. 9, 27 Previous studies exploring predictors of excess IHF in liver resection cohorts were retrospective and relied upon data captured as part of routine clinical assessment and visual assessment of liver histology, however, both excess BMI and diabetes were consistent predictors of steatosis and/or steatohepatitis. 7, 28 Our finding that the median digital intrahepatic fat percentage was 6.89% for the 5 cases graded as "moderate steatosis" by the pathologist (triglyceride content >33% by Kleiner-Brunt criteria 4 ) is consistent with those of previous studies reporting visual estimations of steatosis grade or percentage to be at least 4 times higher than digital histological or biochemical measurements.
18, 29
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Clinical implications
It appears from this study that steatosis and steatohepatitis in liver surgery patients share aetiologies common to those seen in non-alcoholic fatty liver disease (NAFLD). Therefore, strategies that reduce IHF in NAFLD may be effective in surgical patients as well. For example, significant reductions in hepatic triglyceride content (in excess of 50%) can be achieved within a few days of starting a low-carbohydrate diet. 30, 31 Thus, using MR imaging to indirectly quantify IHF content, it may be possible to identify "high risk" patients preoperatively and initiate a low-carbohydrate diet to reduce the chances of post-resection mortality. The next platform of studies should test the reliability and reproducibility of intrahepatic fat measurement in CLM patients using non-invasive imaging and quantify reductions in triglyceride content following dietary intervention.
Strengths and limitations
There are several strengths to this study. First, the data was collected prospectively before liver resection surgery. Previous studies have been retrospective 5 
Future research
There are two key unanswered questions. First, is it feasible to identify patients with moderate/severe steatosis or steatohepatitis before surgery and reduce intra-hepatic fat content? And second, if it is, will this translate into improved peri-operative outcome? In the study by Vauthey et al 5 reporting an increase in peri-operative mortality for steatohepatitis, the interval between finishing chemotherapy and liver resection was less than 6 weeks. In subsequent studies, the chemotherapy to surgery interval has been longer, 7, 28 which may reflect a wider change in practice across other hepatobiliary units. Given the projected increase in the numbers of patients eligible for resection of CLM, and a parallel increase in the prevalence of steatosis in Western populations, better understanding of this topic is likely to benefit many patients. 
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SUPPLEMENTAL METHODS
Validity of the 7-slide technique
Li et al.
1 examined 7 histological sections and scored intra-hepatic fat content as the mean of these 7 scores. Based on this technique, and for pragmatic reasons, we examined 7 slides as well. To test the validity of this technique, in one patient with an average amount of fat on 7 slides, I examined 43 images. The mean digitally quantified histological score from the 43 was 4.30. This was taken as the true mean. I then randomly sampled this data with replacement as samples n = 40, n = 35, n = 30 ……….. n = 4 ( Figure S1 ). Each re-sampling was performed 500 times for each theoretical number of slides. For each number of slides, a distribution (n = 500) of means was derived, which itself had a mean and 5th and 95th
percentiles. If we set the limits of acceptable variation between +25% and -25% of the true mean (i.e. 3.23 and 5.38) the probability that the derived mean lies outside the pre-set limits is high if we examined less than 7 slides. The 7-slide technique was therefore accepted as 'fit for purpose'.
Figure S1
The distribution (n = 500) of means was derived, which has a mean (thick black line) and 5th and 95th percentiles (shaded area). If the limits of acceptable variation are between +25% and -25% of the true mean (3.23 to 5.38, red dashed lines), the probability that the derived mean lies outside these limits is high if we examine less than 7 slides. To assess the reproducibility of the Adobe 7-slide technique, the variability in fat quantification according to (i) the same rater at different time points (intra-rater variability) and by (ii) different raters (inter-rater variability) was assessed using the concordance correlation coefficient (Stata command: concord). Histology measurements were repeated at separate sittings, for the first 19 patients to assess intra-rater variability. A second rater independently analysed histology 7 slides for every fifth patient to assess inter-rater variability for the technique. Both correlations were excellent: the concordance correlation coefficient for intra-rater variability was 0.98; for inter-rater variability it was 0.97.
Intra-and inter-rater variability
Each CT parameter was measured twice at separate sittings to explore intra-rater variability.
A radiologist (Dr Andrew Plumb) performed measurements independently to explore interrater variability. The concordance correlation coefficient was used for the statistical analysis.
Results of inter-and intra-rater variability for the 37 patients ultimately recruited in to the OSCAR study is shown in Table S1 . There was good to excellent agreement for all measurements. In general, WC and SAT and VAT volumes showed the strongest correlations, and inter-rater variability was greater than intra-rater variability. Scatter plots to show inter-rater variability and levels of agreement for the three different VAT measurements (thickness, area and volume) are shown in Figure S2 . 
